EBR Systems: Completes interim enrolment for SOLVE trial

EBR Systems Completes interim enrolment for SOLVE trial

  • EBR Systems (EBR) completes interim patient enrolment in the pivotal SOLVE-CRT IDE trial of WiSE
  • The trial is evaluating the safety and efficacy of the WiSE System in up to 300 patients with acute lead failures, chronic lead failures, high-risk upgrades and leadless upgrades
  • WiSE is a wireless, endocardial pacing system for use in stimulating the heart’s left ventricle which is believed to be the more anatomically correct location for pacing equipment
  • EBR has also executed a five-year agreement for a US$50 million (A$72.63 million) growth capital facility with venture debt provider, Runway Growth Capital
  • Shares in EBR are up 41 per cent and were trading at 53 cents at 1:12 pm
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Former Royal Mint Executives Secure Backing for Precious Metals Trading Platform

New platform aims to modernize precious metals trading for investors.Highlights: Former Royal Mint executives launch a new trading...

Coastal Bank Partners with Tempo to Strengthen Cross-Border Money Transfers

The partnership aims to enhance international money movement solutions.Highlights: Coastal Bank has partnered with Tempo for improved cross-border...

Lloyds Accelerates Homebuying with Fully Digital Service

New platform aims to reduce waiting times for mortgage approvals.Highlights: Lloyds introduces a fully digital homebuying service.Service aims...

AI in Fintech: Revolutionizing the Financial Industry

AI in fintech is changing how financial services operate. It's more than just a buzzword; it's a powerful...